Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Safety and Efficacy of Preoperative Antithrombin Supplementation in Patients Undergoing High-Risk Cardiopulmonary Bypass

ClinicalTrials.gov ID: NCT02037555

Public ClinicalTrials.gov record NCT02037555. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 12:10 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Preoperative Antithrombin Supplementation in Patients Undergoing High-Risk Cardiac Surgery With Cardiopulmonary Bypass

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a prospective, multicenter, randomized, double-blind, placebo-controlled study. The purpose of this study is to determine the safety and effectiveness of human-derived antithrombin III (AT-III \[Human\]) supplementation prior to high-risk, non-emergency, cardiac surgery with cardiopulmonary bypass (CPB). A total of 404 adult subjects undergoing CPB who meet the study eligibility criteria were planned to be randomized to receive either AT-III (Human) or placebo.

Study identification

NCT ID
NCT02037555
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Grifols Therapeutics LLC
Industry
Enrollment
425 participants

Conditions and interventions

Interventions

Biological · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 26, 2014 (Actual)
Primary completion
Jan 25, 2018 (Actual)
Completion
Jan 25, 2018 (Actual)
Last update posted
Mar 15, 2019

2014 – 2018

United States locations

U.S. sites
41
U.S. states
24
U.S. cities
39
Facility City State ZIP Site status
UC Irvine Orange California 92868 —
VA Medical Center - San Francisco San Francisco California 94121 —
Stanford University Hospital and Clinics Stanford California 94305 —
University of Colorado Aurora Colorado 80045 —
Yale University School of Medicine New Haven Connecticut 06510 —
University of Florida College of Medicine Gainesville Florida 32610 —
Jackson Memorial Hospital at University of Miami Miami Florida 33136 —
Emory University Hospital Atlanta Georgia 30322 —
Georgia Regents University Augusta Georgia 30912 —
Memorial Medical Center Springfield Illinois 62794 —
Indiana Ohio Heart Fort Wayne Indiana 46804 —
St. Vincent Heart Center of IN, LLC Indianapolis Indiana 46290 —
Kentucky Clinic Lexington Kentucky 40536 —
Tulane University Medical New Orleans Louisiana 70112 —
Maine Medical Center Portland Maine 04102 —
Brigham & Women's Hospital Boston Massachusetts 02115 —
Sparrow Clinical Research Institute Lansing Michigan 48910 —
William Beaumont Hospital Royal Oak Michigan 48073 —
Saint Luke's Hospital Kansas City Missouri 64111 —
Missouri Baptist Medical Center St Louis Missouri 63131 —
CHI Health Nebraska Heart Medical Office Lincoln Nebraska 68526 —
University of Nebraska Medical Center Omaha Nebraska 68198 —
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03766 —
North Shore University Hospital New Hyde Park New York 11040 —
Duke University Medical Center Durham North Carolina 27710 —
Sanford Health Fargo Fargo North Dakota 58103 —
Summa Health Hospital Akron Ohio 44304 —
The Lindner Center for Research & Education - The Christ Hospital Cincinnati Ohio 45219 —
University Hospitals Case Medical Center Cleveland Ohio 44106 —
The Ohio State University Wexner Medical Center Columbus Ohio 43210 —
ProMedica Toledo Hospital Toledo Ohio 43606 —
University of Toledo Medical Center Toledo Ohio 43614 —
Oregon Health & Science University Portland Oregon 97239 —
University of Pennsylvania Philadelphia Pennsylvania 19104 —
UPMC Presbyterian Hospital Pittsburgh Pennsylvania 15213 —
Baptist Memorial Hospital Memphis Memphis Tennessee 38120 —
St. Thomas Health Nashville Tennessee 37205 —
Memorial Hermann Memorial City Medical Center Bellaire Texas 77401 —
Texas Heart Houston Texas 77030 —
Cardiothoracic Surgical Associates Richmond Virginia 23225 —
Virginia Commonwealth University Medical Center Richmond Virginia 23298 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02037555, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 15, 2019 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02037555 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →